标题
The immunological function of CD52 and its targeting in organ transplantation
作者
关键词
CD52, Grafts, Transplantation, Immune rejection
出版物
INFLAMMATION RESEARCH
Volume 66, Issue 7, Pages 571-578
出版商
Springer Nature
发表日期
2017-03-11
DOI
10.1007/s00011-017-1032-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alteration of CD39+Foxp3+ CD4 T cell and cytokine levels in EAE/MS following anti-CD52 treatment
- (2017) Anudeep B. Pant et al. JOURNAL OF NEUROIMMUNOLOGY
- Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients
- (2017) Irene K. Kim et al. TRANSPLANTATION
- Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial
- (2017) Ondrej Viklicky et al. PLoS One
- Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease
- (2016) Santosh L. Saraf et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD
- (2016) S-K Tey et al. BONE MARROW TRANSPLANTATION
- Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies
- (2016) Jun-ichi Masuyama et al. CYTOTHERAPY
- Refractory Adult Primary Autoimmune Neutropenia that Responded to Alemtuzumab
- (2016) Anu R. Neerukonda et al. INTERNAL MEDICINE
- Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients
- (2016) Edward J. Fox et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Use of non-irradiated blood components in Campath (alemtuzumab)-treated renal transplant patients
- (2016) Y. M. T. Hui et al. TRANSFUSION MEDICINE
- Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT
- (2015) R. A. Marsh et al. BLOOD
- Alemtuzumab: A Review of Its Use in Patients with Relapsing Multiple Sclerosis
- (2014) Karly P. Garnock-Jones DRUGS
- The Effects of CAMPATH-1H on Cell Viability Do Not Correlate to the CD52 Density on the Cell Surface
- (2014) Fuiyee Lee et al. PLoS One
- Lowering the alemtuzumab dose in reduced intensity conditioning allogeneic hematopoietic cell transplantation is associated with a favorable early intense natural killer cell recovery
- (2013) Frank Gärtner et al. CYTOTHERAPY
- Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing-Remitting Multiple Sclerosis
- (2013) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10
- (2013) Esther Bandala-Sanchez et al. NATURE IMMUNOLOGY
- Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys
- (2013) M.R.L. Marco et al. TRANSPLANT IMMUNOLOGY
- Impact of Antimouse CD52 Monoclonal Antibody on Graft’s γδ Intraepithelial Lymphocytes After Orthotopic Small Bowel Transplantation in Mice
- (2013) Bo Shen et al. TRANSPLANTATION
- Patterns ofDe NovoAllo B Cells and Antibody Formation in Chronic Cardiac Allograft Rejection After Alemtuzumab Treatment
- (2012) J. Kwun et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis
- (2012) Sambasiva P. Rao et al. PLoS One
- Alemtuzumab induction of intracellular signaling and apoptosis in malignant B lymphocytes
- (2011) Tri-Hung Nguyen et al. LEUKEMIA & LYMPHOMA
- The role of B cells in solid organ transplantation
- (2011) Jean Kwun et al. SEMINARS IN IMMUNOLOGY
- Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective
- (2010) N Schub et al. BONE MARROW TRANSPLANTATION
- Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity
- (2010) Joanne L. Jones et al. BRAIN
- Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations
- (2010) Mandy L Ford et al. Current Opinion in Organ Transplantation
- Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models
- (2010) William M. Siders et al. LEUKEMIA & LYMPHOMA
- Neutrophils express CD52 and exhibit complement-mediated lysis in the presence of alemtuzumab
- (2009) L. R. Ambrose et al. BLOOD
- Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
- (2009) Yanping Hu et al. IMMUNOLOGY
- Graft-versus-host disease
- (2009) James LM Ferrara et al. LANCET
- Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients
- (2009) Roniel Cabrera et al. LIVER TRANSPLANTATION
- Targeting of Natural Killer Cells by Rabbit Antithymocyte Globulin and Campath-1H: Similar Effects Independent of Specificity
- (2009) Diana Stauch et al. PLoS One
- Contribution of B Cells and Antibody to Cardiac Allograft Vasculopathy
- (2009) Alison Gareau et al. TRANSPLANTATION
- The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease
- (2008) E. M. Dunbar et al. HAEMATOLOGICA
- Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells
- (2008) Che K Lim et al. Journal of Hematology & Oncology
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Alemtuzumab Induction in Kidney Transplantation: Clinical Results and Impact on T-Regulatory Cells
- (2008) J. Morales et al. TRANSPLANTATION PROCEEDINGS
- Long-term immune reconstitution after anti-CD52–treated or anti-CD34–treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency
- (2007) Mary A. Slatter et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started